ERBB2 and breast cancer: Subsequently, we tested the anti-HER2 ADCs for antigen binding affinity and specificity using the human breast cancer cell lines KPL-4 (HER2 positive) and MDA-MB-231 (HER2 negative) (Supplementary Fig. 10 and Supplementary Table 2).